We respond to report showing that attendance at breast screenings has fallen to new decade-low

The proportion of women aged 50-70 taking up routine breast screening fell to 70.5% in 2017-18, down from 71.1% in 2016-17, according to the Breast...

28 February 2019

We respond to potential new treatment for metastatic triple negative breast cancer

New research published this week in the New England Journal of Medicine has found that a new drug – sacituzumab – is effective in stopping growth of...

22 February 2019

We respond to NAO report into the management of health screening programmes in England

The National Audit Office (NAO) has today published its new report into the management of health screening, finding that the proportion of eligible...

1 February 2019

We respond to survey revealing that one in four women don’t check their breasts for signs of cancer

A survey by Bupa and HCA Healthcare UK has suggested that almost six million women in the UK could be putting their health at risk by not checking...

31 January 2019

Breast awareness poll "reiterates what women tell us on our helpline every day"

Discussing the news that one in four women in the UK don’t check their breasts and many would delay seeking help, Carolyn Rogers, Clinical Nurse...

31 January 2019

We respond to new ONS statistics on cancer survival in England

New statistics on cancer survival in England, released today by the Office of National Statistics (ONS), reveal the one-year, five-year and ten-year...

24 January 2019

Moving Forward shortlisted for HSJ Partnership Awards

Discussing the news that Breast Cancer Care’s Moving Forward service, run in partnership with 70 NHS hospital trusts and health boards across the UK...

22 January 2019

We respond to NICE’s approval of abemaciclib for routine NHS use

The National Institute for Health and Care Excellence (NICE) has published new draft guidance recommending breast cancer drug abemaciclib with an...

17 January 2019

Treatment options for secondary breast cancer increase as abemaciclib approved on NHS

Responding to the decision by the National Institute for Health and Care Excellence (NICE) to approve abemaciclib with an aromatase inhibitor for...

17 January 2019